Raymond James Financial Inc Inmune Bio, Inc. Transaction History
Raymond James Financial Inc
- $280 Billion
- Q2 2025
A detailed history of Raymond James Financial Inc transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 333,477 shares of INMB stock, worth $807,014. This represents 0.0% of its overall portfolio holdings.
Number of Shares
333,477
Previous 382,041
12.71%
Holding current value
$807,014
Previous $2.98 Million
74.19%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding INMB
# of Institutions
102Shares Held
6.32MCall Options Held
1.64MPut Options Held
3.35M-
Vanguard Group Inc Valley Forge, PA848KShares$2.05 Million0.0% of portfolio
-
Black Rock Inc. New York, NY813KShares$1.97 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$1.44 Million45.87% of portfolio
-
Ubs Group Ag449KShares$1.09 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA390KShares$943,6330.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $43.4M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...